These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 25756134)

  • 1. Avoiding obsolescence in advanced prostate cancer management: a guide for urologists.
    Shore ND; Karsh L; Gomella LG; Keane TE; Concepcion RS; Crawford ED
    BJU Int; 2015 Feb; 115(2):188-97. PubMed ID: 25756134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer.
    Fowler FJ; McNaughton Collins M; Albertsen PC; Zietman A; Elliott DB; Barry MJ
    JAMA; 2000 Jun; 283(24):3217-22. PubMed ID: 10866869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A National Survey of Radiation Oncologists and Urologists on Perceived Attitudes and Recommendations of Active Surveillance for Low-Risk Prostate Cancer.
    Kim SP; Tilburt JC; Shah ND; Yu JB; Konety B; Nguyen PL; Abouassaly R; Williams SB; Gross CP
    Clin Genitourin Cancer; 2019 Jun; 17(3):e472-e481. PubMed ID: 30827923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.
    Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in practice patterns between urologists and radiation oncologists in the management of localized prostate cancer: a cross-sectional survey.
    Ariane MM; Ploussard G; Rebillard X; Malavaud B; Rischmann P; Hennequin C; Mongiat-Artus P
    World J Urol; 2015 Nov; 33(11):1741-7. PubMed ID: 25822706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient preferences and urologist recommendations among local-stage prostate cancer patients who present for initial consultation and second opinions.
    Ramsey SD; Zeliadt SB; Fedorenko CR; Blough DK; Moinpour CM; Hall IJ; Smith JL; Ekwueme DU; Fairweather ME; Thompson IM; Keane TE; Penson DF
    World J Urol; 2011 Feb; 29(1):3-9. PubMed ID: 20959991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selecting men diagnosed with prostate cancer for active surveillance using a risk calculator: a prospective impact study.
    van Vugt HA; Roobol MJ; van der Poel HG; van Muilekom EH; Busstra M; Kil P; Oomens EH; Leliveld A; Bangma CH; Korfage I; Steyerberg EW
    BJU Int; 2012 Jul; 110(2):180-7. PubMed ID: 22112199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knowledge, attitudes and beliefs towards management of men with locally advanced prostate cancer following radical prostatectomy: an Australian survey of urologists.
    Brown B; Young J; Kneebone AB; Brooks AJ; Dominello A; Haines M
    BJU Int; 2016 Apr; 117 Suppl 4():35-44. PubMed ID: 25585989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. United States radiation oncologists' and urologists' opinions about screening and treatment of prostate cancer vary by region.
    McNaughton Collins M; Barry MJ; Zietman A; Albertsen PC; Talcott JA; Walker Corkery E; Elliott DB; Fowler FJ
    Urology; 2002 Oct; 60(4):628-33. PubMed ID: 12385923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variation in Guideline Concordant Active Surveillance Followup in Diverse Urology Practices.
    Luckenbaugh AN; Auffenberg GB; Hawken SR; Dhir A; Linsell S; Kaul S; Miller DC;
    J Urol; 2017 Mar; 197(3 Pt 1):621-626. PubMed ID: 27663459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of androgen ablation in patients with biochemical or local failure after definitive radiation therapy: a survey of practice patterns of urologists and radiation oncologists in the United States.
    Sylvester J; Grimm P; Blasco J; Meier R; Spiegel J; Heaney C; Cavanagh W
    Urology; 2001 Aug; 58(2 Suppl 1):65-70. PubMed ID: 11502452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes to Dutch College of General Practitioners guideline 'Micturition problems in men'].
    Blanker MH; de Reijke TM; van Moorselaar RJ; Opstelten W
    Ned Tijdschr Geneeskd; 2014; 158():A8070. PubMed ID: 25492733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer screening and beliefs about treatment efficacy: a national survey of primary care physicians and urologists.
    Fowler FJ; Bin L; Collins MM; Roberts RG; Oesterling JE; Wasson JH; Barry MJ
    Am J Med; 1998 Jun; 104(6):526-32. PubMed ID: 9674714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physician variation in management of low-risk prostate cancer: a population-based cohort study.
    Hoffman KE; Niu J; Shen Y; Jiang J; Davis JW; Kim J; Kuban DA; Perkins GH; Shah JB; Smith GL; Volk RJ; Buchholz TA; Giordano SH; Smith BD
    JAMA Intern Med; 2014 Sep; 174(9):1450-9. PubMed ID: 25023650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comorbidity and the Receipt of Curative Therapy for Favorable-risk Prostate Cancer Prior to and Following the Publication of PIVOT.
    Mihalcik SA; Chen MH; Braccioforte MH; Moran BJ; D'Amico AV
    Eur Urol Focus; 2018 Jan; 4(1):64-67. PubMed ID: 28753752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does Specialty Bias Trump Evidence in the Management of High-risk Prostate Cancer?
    Kishan AU; Duchesne G; Wang PC; Rwigema JM; Saigal C; Rettig M; Steinberg ML; King CR
    Am J Clin Oncol; 2018 Jun; 41(6):549-557. PubMed ID: 27560157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishing nurse-led active surveillance for men with localised prostate cancer: development and formative evaluation of a model of care in the ProtecT trial.
    Wade J; Holding PN; Bonnington S; Rooshenas L; Lane JA; Salter CE; Tilling K; Speakman MJ; Brewster SF; Evans S; Neal DE; Hamdy FC; Donovan JL;
    BMJ Open; 2015 Sep; 5(9):e008953. PubMed ID: 26384727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perceived barriers to the adoption of active surveillance in low-risk prostate cancer: a qualitative analysis of community and academic urologists.
    Ellis SD; Hwang S; Morrow E; Kimminau KS; Goonan K; Petty L; Ellerbeck E; Thrasher JB
    BMC Cancer; 2021 May; 21(1):649. PubMed ID: 34058998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practice patterns of urologists in managing Korean men aged 40 years or younger with high serum prostate-specific antigen levels.
    Yoo DS; Woo SH; Cho S; Kang SH; Kim SJ; Park SY; Lee SH; Jeon SH; Park J
    Urology; 2014 Jun; 83(6):1339-43. PubMed ID: 24726151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of Care Related to Post-Operative Radiotherapy for Patients with Prostate Cancer among Canadian Radiation Oncologists and Urologists.
    Bristow B; Aldehaim M; Bonin K; Lam CCK; Wan SJ; Cao X; Szumacher E
    J Cancer Educ; 2018 Dec; 33(6):1195-1200. PubMed ID: 28573519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.